Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Preparation of an astatine-211 aqueous solution by dry distillation and dissolution in pure water

Kazuhiro Ooe, Atsushi Toyoshima, Takahiro Teramoto, Kojiro Nagata, Yuichiro Kadonaga, Akimitsu Kanda, Katsuyuki Tokoi, Sota Nakagawa, Tadashi Watabe, Yoshifumi Shirakami, Takashi Yoshimura, Atsushi Shinohara and Jun Hatazawa
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1462;
Kazuhiro Ooe
1Department of Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Toyoshima
2Division of Science, Institute for Radiation Sciences Osaka University Toyonaka, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Teramoto
2Division of Science, Institute for Radiation Sciences Osaka University Toyonaka, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kojiro Nagata
3Radioisotope Research Center, Institute for Radiation Sciences Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichiro Kadonaga
2Division of Science, Institute for Radiation Sciences Osaka University Toyonaka, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akimitsu Kanda
4Department of Chemistry, Graduate School of Science Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuyuki Tokoi
4Department of Chemistry, Graduate School of Science Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sota Nakagawa
4Department of Chemistry, Graduate School of Science Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
1Department of Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshifumi Shirakami
2Division of Science, Institute for Radiation Sciences Osaka University Toyonaka, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Yoshimura
3Radioisotope Research Center, Institute for Radiation Sciences Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Shinohara
4Department of Chemistry, Graduate School of Science Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
5Research Center for Nuclear Physics Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1462

Objectives: Astatine-211 (211At) is a promising radionuclide for targeted alpha therapy of metastatic cancers. The production of 211At is accomplished in the 209Bi(α, 2n)211At nuclear reaction using an accelerator. Typically, 211At is isolated from the irradiated Bi target through a dry distillation method and dissolved in various solutions. In many cases, methanol or chloroform is used as solvent for dry distilled 211At. However, these solutions are toxic to living body, and it is desirable to dissolve dry distilled 211At with non-toxic aqueous solution for clinical use of 211At. Our group have been preparing the clinical trial of [211At]-sodium astatide ([211At]NaAt) as a reagent for targeted alpha therapy of thyroid cancer. This reagent is prepared by adding aqueous ascorbic acid solution to dry distilled 211At dissolved in pure water. Here, we report our recent results of preparation method for dry distilled 211At dissolved in pure water.

Methods: The 211At produced in the 209Bi(α, 2n)211At reaction was supplied from RIKEN through Supply Platform of Short-lived Radioisotopes. The produced 211At was separated from the irradiated Bi target using the dry distillation apparatus shown in Fig. 1. The irradiated Bi target was put in a quartz column and heated up to 850°C using an electric tubular furnace. The evaporated 211At was transported to Teflon trap tube, which is cooled by ice water, with mixed N2 and O2 gas flow including trace moisture added by a moisture generator. The trapped 211At was then dissolved in 100 μL of pure water. The separation yield of 211At was calculated from the 211At radioactivity in the eluted pure water divided by that in the irradiated Bi target measured with a Ge detector.

Results: Approximately 80% of 211At (after decay correction) was trapped in the Teflon trap tube. However, the separation yield of 211At dissolved in 100 μL of pure water fluctuated from 35% to 70%; most of 211At remained in the Teflon trap tube when the separation yield was low. The remained 211At in the trap tube was recovered by 2-6 times repeated dissolution with 100 μL of pure water resulting in total separation yield of 65% to 80%. A rough correlation was observed between the separation yield of 211At and the amount of moisture in the carrier gas during heating of the Bi target, indicating that the proportion of chemical species of 211At which can be easily dissolved in pure water might be affected by the amount of moisture in the carrier gas. Optimization of separation condition would lead to preparation of 211At dissolved in small volume of pure water.

Conclusions: It is expected that, by optimization of separation condition, our preparation method for dry distilled 211At dissolved in pure water would be applied to clinical application of [211At]NaAt for targeted alpha therapy of thyroid cancer.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation of an astatine-211 aqueous solution by dry distillation and dissolution in pure water
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation of an astatine-211 aqueous solution by dry distillation and dissolution in pure water
Kazuhiro Ooe, Atsushi Toyoshima, Takahiro Teramoto, Kojiro Nagata, Yuichiro Kadonaga, Akimitsu Kanda, Katsuyuki Tokoi, Sota Nakagawa, Tadashi Watabe, Yoshifumi Shirakami, Takashi Yoshimura, Atsushi Shinohara, Jun Hatazawa
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1462;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation of an astatine-211 aqueous solution by dry distillation and dissolution in pure water
Kazuhiro Ooe, Atsushi Toyoshima, Takahiro Teramoto, Kojiro Nagata, Yuichiro Kadonaga, Akimitsu Kanda, Katsuyuki Tokoi, Sota Nakagawa, Tadashi Watabe, Yoshifumi Shirakami, Takashi Yoshimura, Atsushi Shinohara, Jun Hatazawa
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1462;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • Diagnostic and prognostic value of chronotropic incompetence on exercise gated 99mTc-MIBI SPECT in patients with suspected CAD
  • Comparison of regadenoson and dypiridamole myocardial blood flow and coronary flow reserve hyperemic response by non-invasive quantitative N-13 ammonia PET.
Show more Poster - PhysicianPharm

Radiopharmacy

  • Radiochemical Purity of Common On-Call Kits Utilizing Tc-99m Eluate Near Its Beyond Use Date
  • The Inconsistencies of Iodine Capsule Dosimetry and Calibration
  • Comparison Between the NorthStar RadioGenix® System and Traditional Dry-Column Generators for the Production of Technetium-99m
Show more Radiopharmacy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire